More specifically, WEE1 and ATR inhibitors caused the synergistic killing of acute myeloid leukemia (AML), biliary tract, and breast cancer cells, likely due to problems arising in S-phase and G2/M [19,20,21,23]. The gene discussed is WEE1; the disease is breast carcinoma.